Latest Quarter
Q2 FY2026ended 2026-06-30 · filed 2026-08-04
$740.31M
$-133.93M
$-137.8M
-$0.99
N/A
$4.34B
$1.38B
$1.89B
What this quarter tells us
For Q1 FY2026 ended March 31, 2026, AdaptHealth reported revenue of $819.8 million, up 5.4% year-over-year. Net loss was $16.0 million, compared to net income in the prior year, with diluted EPS of -$0.12. Operating income fell 76.3% to $5.5 million. The company had long-term debt of $1.82 billion and equity of $1.51 billion.
- •Revenue grew 5.4% YoY to $819.8 million.
- •Net loss of $16.0 million vs. prior year net income.
- •Diluted EPS of -$0.12, down 140% YoY.
- •Operating income declined 76.3% to $5.5 million.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.